Medicine Name: Epofer 4000 IU Injection Active Ingredient: Recombinant Human Erythropoietin Alfa (Epoetin alfa) — 4000 IU per ml (International Units) Dosage Form: Sterile solution for injection (pre‑filled syringe or vial) Strength: 4000 IU of erythropoietin per ml Therapeutic Class: Hematopoietic agent / Erythropoiesis‑stimulating agent (ESA) Route of Administration: Parenteral – given intravenously (IV) or subcutaneously (SC) by healthcare provider Composition Each 1 ml contains: Recombinant Human Erythropoietin Alfa (Epoetin alfa) – 4000 IU Excipients/inactive components (buffers, stabilizers) – formulation details vary by manufacturer (commonly citrate buffer, sodium chloride, etc.). Therapeutic Use Stimulates bone marrow to increase red blood cell production. Helps correct anemia (low red blood cell count/low hemoglobin) in various clinical conditions. Epofer 4000 injection (Erythropoietin) treats anemia by stimulating the bone marrow to produce more red blood cells, primarily for conditions like anemia from chronic kidney disease (CKD), cancer chemotherapy, HIV treatments, and bone marrow disorders, helping reduce fatigue and the need for blood transfusions. It's also used before major surgeries to prepare patients for reduced blood loss, given by injection under the skin or into a vein. Chronic Kidney Disease (CKD): Treats anemia in adults and children on dialysis and those with CKD. Cancer Therapy: Manages anemia caused by chemotherapy or anti-viral treatments (like for HIV). Bone Marrow Disorders: Addresses low red blood cell counts from conditions like myelodysplastic syndromes. Surgical Preparation: Reduces the need for blood transfusions in patients undergoing major bone surgery (like hip/knee replacements). Treatment of Anemia Used to increase red blood cell (RBC) count in patients with anemia. Commonly prescribed in anemia associated with: Chronic kidney disease (CKD) — patients on dialysis or with reduced kidney function Chemotherapy-induced anemia in cancer patients Chronic illnesses causing low hemoglobin Pre-operative anemia to reduce the need for blood transfusions Blood Production Support Stimulates bone marrow to produce more red blood cells. Helps improve hemoglobin and hematocrit levels, reducing fatigue, weakness, and pallor. How It Works Erythropoietin binds to receptors on red blood cell precursors in the bone marrow. Promotes maturation of red blood cells, increasing oxygen-carrying capacity of the blood. Packaging & Storage Pack Type: Often supplied as pre‑filled syringe or vial containing 1 ml of solution. Storage: Refrigerate at 2 °C–8 °C Do not freeze Protect from light and shaking